Pharmacokinetic Tumor Heterogeneity as a Prognostic Biomarker for Classifying Breast Cancer Recurrence Risk. - Majid Mahrooghy; Ahmed Bilal Ashraf; Dania Daye; Elizabeth S. McDonald; Mark Rosen; Carolyn Mies; Michael D. Feldman; Despina Kontos (IEEE Trans. Biomed. Eng., 2015)

Summary of Outcomes from Consecutive Years of Tomosynthesis Screening at an American Academic Institution. - Emily F. Conant; Andrew Oustimov; Samantha P. Zuckerman; Elizabeth S. McDonald; Susan P. Weinstein; Andrew D. A. Maidment; Bruno Barufaldi; Marie Synnestvedt; Mitchell D. Schnall (Digital Mammography / IWDM, 2016)

Diagnostic radiation dose after the implementation of digital breast tomosynthesis screening. - Bruno Barufaldi; Elizabeth S. McDonald; Emily F. Conant; Andrew D. A. Maidment (IWBI, 2018)

Acquisition parameters for dual-energy contrast-enhanced digital mammography using a micelle-based all-in-one nanoparticle (AION) contrast agent: a phantom study. - Kristen C. Lau; Jessica C. Hsu; Pratap C. Naha; Peter Chhour; Renee Hastings; Joel M. Stein; Elizabeth S. McDonald; David P. Cormode; Andrew D. A. Maidment (IWBI, 2018)